CLDI Appoints Corsee Sanders
Calidi Biotherapeutics appoints Corsee Sanders, Ph.D., to its Board of Directors, bringing over three decades of biopharmaceutical development experience
CLDI - Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of DirectorsIndustry Veteran Brings More Than Three Decades of Biopharmaceutical Development and Clinical Operations Experience to Help Guide Pipeline Advancement